Search Results 8471-8480 of 34181 for oral
Patients randomized to GDC-0199+R will be given GDC-0199 daily (oral, target dose 400 mg) and will receive 6 cycles of rituximab infused intravenously (IV) ...
Olson, M.D., M.S.. Rochester, MN. Areas of focus: Facial fracture repair, Rhinoplasty, Oral surgery, Face lift, Glossectomy, Nasal valve repair, Tonsillectomy ...
Ettinger, M.D., D.D.S. — Oral and Maxillofacial Surgeon, Surgical Oncologist; Robert P. Frantz, M.D. — Cardiologist, Internist; Allison E. Garda, M.D. ...
Patients with any condition that may impair the ability to absorb oral medications/investigational product including: Prior surgical procedures affecting ...
Immunosuppressive or immunomodulating treatment, including chronic oral or IV steroids, must be discontinued at least 4 weeks prior to screening. History of ...
Departments that treat this condition. Dental Specialties · Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Sleep ...
... Oral and throat cancer, Salivary gland cancer, Mouth cancer, Thyroid cancer, Head and neck cancer, Melanoma, Tonsil cancer, Skin cancer, Squamous cell ...
Oral and Maxillofacial Surgery · Oral Cavity Cancer and Reconstruction Clinic in Minnesota · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology ...
Note 2: Use of oral corticosteroids for nondermatological conditions (eg, asthma exacerbation, bronchitis) is allowed for no longer than 7 days if deemed ...
Oral and Maxillofacial Surgery · Oropharynx Cancer Clinic in Minnesota · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Plastic ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.